Wall Street Predicted a Blockbuster. Now the Drug May Be Withdrawn.
Wall Street Journal
Amylyx’s ALS drug failed a late-stage trial, raising questions about the future of the drug and the company itself.
Understanding current events through the lenses of the past and future.
Wall Street Journal
Amylyx’s ALS drug failed a late-stage trial, raising questions about the future of the drug and the company itself.